Sorted By:


Medicare Monday: Helping Hypertensive Patients Live Healthier Lives

PhRMA  |  Blog Post

Please leave your story below and follow #MedicareMonday on Facebook and Twitter for more about how the program is helping individuals get the medicines they need to live longer, healthier lives.

Researching Alzheimer’s Medicines: Setbacks and Stepping Stones

PhRMA  |  Policy Paper

Biopharmaceutical researchers and the companies they work for are committed to finding treatments that realize the promise of our expanding scientific knowledge to halt or prevent the disease.

More Than 7,000 Medicines in Development Globally

Chartpack  |  From Our Network

Biopharmaceutical researchers are working across the globe to research and develop more than 7,000 medicines for diseases, including cancer, infectious diseases, diabetes, HIV/AIDS and immunological disorders.

Twenty-Five Years of Progress Against Hepatitis C: Setbacks and Stepping Stones

PhRMA  |  Report

These medicines promise to improve cure rates further, reduce side effects and duration of treatment, and expand treatment options.

High Cholesterol Patient Profile - Betty

PhRMA  |  Graphic


Five Things You Might Not Know About Medicare Part D

PhRMA  |  Blog Post

And a recent CBO analysis found between 2007 and 2010 lower bids were submitted in regions with more plan sponsors and more competition.

ICYMI – WSJ commentary: The folly of targeting big pharma

PhRMA  |  Blog Post

 For example, in the fight against Alzheimer’s disease, a new medicine that delays the onset of Alzheimer’s disease by five years would avoid $367 billion annually in long-term care and other health care costs by 2050.

New Report: Clinical Trials and the Impact on State Economies

PhRMA  |  Blog Post

What it shows is that industry sponsored clinical trials are not only vital to the development of new treatments and cures for patients, but also play an important role in sustaining economic growth in communities throughout the country.

Reauthorize the Prescription Drug User Fee Act

PhRMA  |  Graphic

Reauthorization of the Prescription Drug, Biosimilar and Generic Drug User Fee Acts is crucial to ensuring innovative new medicines continue to reach patients in need.

Medicare Monday Then & Now: Competition

PhRMA  |  Graphic


ICYMI – New York Times Editorial Board: Hepatitis C medicines a high value for patients and health care system

PhRMA  |  Blog Post

/AIDS counseled removing the “unreasonable” restrictions, noting that the increasingly competitive marketplace had “dramatically reduced” treatment costs and improved benefits to the nation's patients.

High Cholesterol Patient Profile - Bill

PhRMA  |  Graphic


PhRMA Principles for Payment and Delivery System Reforms

PhRMA  |  Codes & Guidelines

In addition, certain payment models can create substantial disincentives for use of innovative treatments.

Embracing 21st Century Information Sharing: Defining a New Paradigm for the FDA and Communications with Health Care Professionals

PhRMA  |  Blog Post

Get updates on this subject and/or other relevant issues here.

PhRMA launches biologics and biosimilars online resources

PhRMA  |  Blog Post

Our goal is to create a comprehensive source of information on biologics and biosimilars, so that we can help improve awareness, science and evidence-based decision-making and patient choice.

Modern Doctors’ House Calls: Skype Chat And Fast Diagnosis

From Hope To Cures  |  From Our Network

” When the doctor appeared on her screen, she told him her symptoms and, holding her iPad close to her face, showed him her painful tooth and the swelling in her jaw.

Policies to combat prescription drug abuse and misuse

PhRMA  |  Blog Post

Learn more about how PhRMA and its member companies are working to prevent the misuse and abuse of prescription medicines.

Biopharmaceutical Research Companies Developing 92 Medicines to Treat Arthritis and Musculoskeletal Diseases

PhRMA  |  Blog Post

We look forward to hearing from the contributors and from you about how we can continue the progress in helping patients with arthritis and related diseases.

Big Changes in Fine Print of Some 2015 Health Plans

Access Better Coverage  |  From Our Network

About 180 plans are being discontinued for at least some customers, and the rest are keeping the same limits.

ICYMI: Ubl weighs in on how fair trade protects US biopharmaceutical innovation

PhRMA  |  Blog Post

That is why, as Ubl explains, it is critical the United States negotiates trade deals that are in the national interest, and that those deals are actively monitored and enforced to ensure other nations adhere to agreed-upon terms.

Spending on Medicines: The Big Picture

PhRMA  |  Blog Post

We can’t afford to have a health care system that doesn’t support innovation and encourage the development of new treatments for these and other costly conditions.

A Look at How to Best Promote Healthy Lifestyles and Adherence to Diabetes Medication

PhRMA  |  Blog Post

As the “captain” meets with his/her coaches, our approach should be as supportive and positive as possible in order to enhance adherence to both medication and required lifestyle changes.

Medicare Monday: CMS withdraws Part B demo, takes positive step forward on CMMI

PhRMA  |  Blog Post

Learn more about CMMI at

Medicare Monday: New Research on How Successfully Managing Diabetes Helps Patients and Part D Save

PhRMA  |  Blog Post

Improving medication adherence through programs like medication therapy management and other initiatives is important not only to ensure patient health, but also to help reduce costs in the health care system overall.

Fighting HIV/AIDS

From Hope To Cures  |  From Our Network

1.1 million Americans are living with HIV

You have reviewed the first 325 results out of 2649. Each page contains 25 results. You're on page 13.

prev 13 14 15 16 17 18 next